Supplementary Text and Figures
Supplementary Figures 1â€“13 (PDF 5271 kb)

Supplementary Table 1
Summary of individual groups subtyping strategy (XLSX 17 kb)

Supplementary Table 2
Summary of clinical, pathological and molecular associations of individual groups' subtypes (XLSX 17 kb)

Supplementary Table 3
Data sets and variables used for correlative analyses (XLSX 19 kb)

Supplementary Table 4
Report of Random Forest CMS classifier during training and validation steps (XLSX 11 kb)

Supplementary Table 5
Clinicopathological and molecular associations of CMS groups (XLSX 24 kb)

Supplementary Table 6
Adjusted P values for enrichment in selected copy number counts across CMS groups (XLSX 15 kb)

Supplementary Table 7
Adjusted P values for enrichment in reverse-phase protein array measurements across CMS groups (XLSX 21 kb)

Supplementary Table 8
Adjusted P values for enrichment in cancer drivers mutations across CMS groups (XLSX 22 kb)

Supplementary Table 9
Adjusted P values for gene set mRNA enrichment analysis (XLSX 20 kb)

Supplementary Table 10
Comparison of TCGA proteomic subtypes and CMS groups (XLSX 11 kb)

Supplementary Table 11
Adjusted P values for gene set protein enrichment analysis (XLSX 18 kb)

Supplementary Table 12
Differential microRNA expression levels across CMS groups (XLSX 53 kb)

Supplementary Table 13
Univariate and multivariate survival models (XLSX 19 kb)

Supplementary Table 14
Major clinicopathological and molecular features of classified and undeterminate samples (XLSX 15 kb)

Supplementary Table 15
Major clinicopathological and molecular features of samples with network labels (consensus samples) versus samples with classifier labels (non-consensus classified samples) for each CMS group (XLSX 18 kb)

Supplementary Table 16
Final performance metrics of CMS classifiers (Random Forest and Single Sample Predictor) applied to consensus samples (XLSX 13 kb)